

Senate
Study
Bill
1021
-
Introduced


SENATE/HOUSE
FILE
_____


BY
(PROPOSED
BOARD
OF
PHARMACY


BILL)


A
BILL
FOR


An
Act
relating
to
the
board
of
pharmacy,
including
nonresident
1


pharmacy
and
outsourcing
facility
licensure,
pharmacist
2


supervision
of
pharmacy
technicians,
alternate
board
3


members,
and
enforcement
authority.
4


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
5


TLSB
1217DP
(3)
86


tr/nh



S.F.
_____
H.F.
_____


Section
1.
Section
147.107,
subsection
2,
paragraph
a,
Code
1


2015,
is
amended
to
read
as
follows:
2


a.
A
pharmacist,
physician,
dentist,
or
podiatric
physician
3


who
dispenses
prescription
drugs,
including
but
not
limited
4


to
controlled
substances,
for
human
use,
may
delegate
5


nonjudgmental
dispensing
functions
to
staff
assistants
only
6


when
verification
of
the
accuracy
and
completeness
of
the
7


dispensing
is
determined
by
the
pharmacist
or
practitioner
8


in
the
pharmacist’s
or
practitioner’s
physical
presence.
9


However,
the
physical
presence
requirement
does
not
apply
10


when
a
pharmacist
or
practitioner
is
utilizing
an
automated
11


dispensing
system
;


or
when
a
pharmacist
is
utilizing
a
12


tech-check-tech
program,
as
defined
in
section
155A.3
;
or
when
13


a
pharmacist
is
remotely
supervising
a
certified
pharmacy
14


technician
practicing
at
a
telepharmacy
site
approved
by
the
15


board
of
pharmacy
.
When
using
an
automated
dispensing
system
16


the
pharmacist
or
practitioner
shall
utilize
an
internal
17


quality
control
assurance
plan
that
ensures
accuracy
for
18


dispensing.
When
using
a
tech-check-tech
program
or
when


19


remotely
supervising
a
certified
pharmacy
technician
practicing
20


at
an
approved
telepharmacy
site,


the
pharmacist
shall
utilize
21


an
internal
quality
control
assurance
plan,
in
accordance
22


with
rules
adopted
by
the
board
of
pharmacy,
that
ensures
23


accuracy
for
dispensing.
Verification
of
automated
dispensing
,


24


and


tech-check-tech
,
and
telepharmacy
practice
accuracy
and
25


completeness
remains
the
responsibility
of
the
pharmacist
or
26


practitioner
and
shall
be
determined
in
accordance
with
rules
27


adopted
by
the
board
of
pharmacy,
the
board
of
medicine,
the
28


dental
board,
and
the
board
of
podiatry
for
their
respective
29


licensees.
30


Sec.
2.
NEW
SECTION


.
155A.2A
Board
of
pharmacy
——
alternate
31


members.
32


Notwithstanding
sections
17A.11,
69.16,
69.16A,
147.12,
33


147.14,
and
147.19,
the
board
may
have
a
pool
of
up
to
seven
34


alternate
members,
including
members
licensed
to
practice
under
35


-1-


LSB
1217DP
(3)
86


tr/nh
1/
13
















S.F.
_____
H.F.
_____


this
chapter
and
members
not
licensed
to
practice
under
this
1


chapter,
to
substitute
for
board
members
who
are
disqualified
2


or
become
unavailable
for
any
other
reason
for
contested
case
3


hearings.
4


1.
The
board
may
recommend,
subject
to
approval
by
the
5


governor,
up
to
seven
people
to
serve
in
a
pool
of
alternate
6


members.
7


2.
A
person
serves
in
the
pool
of
alternate
members
at
8


the
discretion
of
the
board;
however,
the
length
of
time
an
9


alternate
member
may
serve
in
the
pool
shall
not
exceed
nine
10


years.
A
person
who
serves
as
an
alternate
member
may
later
be
11


appointed
to
the
board
and
may
serve
nine
years,
in
accordance
12


with
sections
147.12
and
147.19.
A
former
board
member
may
13


serve
in
the
pool
of
alternate
members.
14


3.
An
alternate
member
licensed
under
this
chapter
shall
15


hold
an
active
license
and
shall
have
been
actively
engaged
in
16


the
practice
of
pharmacy
in
the
preceding
three
years,
with
the
17


two
most
recent
years
of
practice
being
in
Iowa.
18


4.
When
a
sufficient
number
of
board
members
are
unavailable
19


to
hear
a
contested
case,
the
board
may
request
alternate
20


members
to
serve.
21


5.
Notwithstanding
section
17A.11,
section
147.14,
22


subsection
2,
and
section
272C.6,
subsection
5:
23


a.
An
alternate
member
is
deemed
a
member
of
the
board
only
24


for
the
hearing
panel
for
which
the
alternate
member
serves.
25


b.
A
hearing
panel
containing
alternate
members
must
include
26


at
least
five
people.
27


c.
The
majority
of
a
hearing
panel
containing
alternate
28


members
shall
be
current
members
of
the
board.
29


d.
The
majority
of
a
hearing
panel
containing
alternate
30


members
shall
be
licensed
to
practice
under
this
chapter.
31


e.
A
decision
of
a
hearing
panel
containing
alternate
32


members
is
considered
a
final
decision
of
the
board.
33


6.
An
alternate
member
shall
not
receive
compensation
in
34


excess
of
that
authorized
by
law
for
a
board
member.
35


-2-


LSB
1217DP
(3)
86


tr/nh
2/
13



S.F.
_____
H.F.
_____


Sec.
3.
Section
155A.3,
subsections
10
and
11,
Code
2015,
1


are
amended
to
read
as
follows:
2


10.
“Device”
means
an
instrument,
apparatus,
implement,
3


machine,
contrivance,
implant,
in
vitro
reagent,
or
other
4


similar
or
related
article,
including
any
component
part
or
5


accessory
of
any
of
these


,
that
is
required
under
federal
or
6


state
law
to
be
ordered
or
prescribed
by
a
practitioner.


which
7


is
any
of
the
following:
8


a.
Recognized
as
a
device
in
the
official
United
States
9


pharmacopoeia
national
formulary
or
any
supplement
thereto.
10


b.
Intended
for
use
in
the
diagnosis
of
diseases
or
11


other
conditions,
or
in
the
cure,
mitigation,
treatment,
or
12


prevention
of
diseases
or
other
conditions
in
a
human.
13


c.
Intended
to
affect
the
structure
or
any
function
of
14


the
body
of
a
human,
and
which
does
not
achieve
any
of
its
15


principal
intended
purposes
through
chemical
action
within
16


or
on
the
body
of
a
human
and
which
is
not
dependent
upon


17


being
metabolized
for
the
achievement
of
any
of
its
principal
18


intended
purposes.
19


11.
“Dispense”
means
to
deliver
a
prescription
drug,
20


device,
or
controlled
substance
to
an
ultimate
user
or
research
21


subject
by
or
pursuant
to
the
lawful
prescription
drug
order
or
22


medication
order
of
a
practitioner,
including
the
prescribing,
23


administering,
packaging,
labeling,
or
compounding
necessary
24


to
prepare
the


a
substance
for
that
delivery
,
or
measuring,
25


fitting,
adjusting,
or
otherwise
facilitating
the
use
of
a


26


medical
device
or
equipment
by
the
patient
.
27


Sec.
4.
Section
155A.3,
Code
2015,
is
amended
by
adding
the
28


following
new
subsections:
29


NEW
SUBSECTION
.
17A.
“Equipment”
means
any
durable
or
30


nondurable
medical
product
or
article,
including
but
not
31


limited
to
medical
products
or
articles
for
personal
use.
32


NEW
SUBSECTION


.
40A.
“Telepharmacy”
means
the
practice
of
33


pharmacy
via
telecommunications
as
provided
by
the
board
by
34


rule.
35


-3-


LSB
1217DP
(3)
86


tr/nh
3/
13
































S.F.
_____
H.F.
_____


Sec.
5.
Section
155A.13A,
Code
2015,
is
amended
to
read
as
1


follows:
2


155A.13A
Nonresident
pharmacy
license
——
required,
renewal,
3


discipline.
4


1.
License
required.
A
pharmacy
located
outside
of
this
5


state
which


that
delivers,
dispenses,
or
distributes
by
any
6


method,
prescription
drugs
or
devices
to
an
ultimate
user
in
7


this
state
shall
obtain
a
nonresident
pharmacy
license
from
8


the
board.
The
board
shall
make
available
an
application
form
9


for
a
nonresident
pharmacy
license
and
shall
require
such
10


information
it
deems
necessary
to
fulfill
the
purposes
of
this
11


section
.
A
nonresident
pharmacy
shall
do
all
of
the
following
12


in
order
to
obtain
a
nonresident
pharmacy
license
from
the
13


board:
14


a.
Submit
a
completed
application
form
and
an
application
15


fee
as
determined
by
the
board.
16


b.
Submit
evidence
of
possession
of
a
valid
pharmacy


17


license,
permit,
or
registration
as
a
pharmacy
in
compliance
18


with
the
laws
of
the
state
in
which
it
is
located,
a
copy
of
19


the
most
recent
inspection
report
resulting
from
an
inspection
20


conducted
by
the
regulatory
or
licensing
agency
of
the
state


21


in
which
it
is
located,
and
evidence
of
compliance
with
all


22


legal
directions
and
requests
for
information
issued
by
the
23


regulatory
or
licensing
agency
of
the
state
in
which
it
is
24


located


issued
by
the
home
state
licensing
authority
.
25


c.
(1)


Submit
a
list
of
the
names,
titles,
and
locations
of
26


all
principal
owners,
partners,
or
officers
of
the
nonresident
27


pharmacy,
all
pharmacists
employed
by
the
nonresident
pharmacy
28


who
deliver,
dispense,
or
distribute
by
any
method
prescription
29


drugs
to
an
ultimate
user
in
this
state,
and
of
the
pharmacist
30


in
charge
of
the
nonresident
pharmacy.
A
nonresident
pharmacy


31


shall
update
the
list
within
thirty
days
of
any
addition,


32


deletion,
or
other
change
to
the
list.


Submit
an
inspection
33


report
that
satisfies
all
of
the
following
requirements:


34


(a)


Less
than
two
years
have
passed
since
the
date
of
35


-4-


LSB
1217DP
(3)
86


tr/nh
4/
13





























S.F.
_____
H.F.
_____


inspection.
1


(b)


The
inspection
occurred
while
the
pharmacy
was
in
2


operation.
An
inspection
prior
to
the
initial
opening
of
the
3


pharmacy
shall
not
satisfy
this
requirement.
4


(c)
The
inspection
report
addresses
all
aspects
of
the
5


pharmacy’s
business
that
will
be
utilized
in
Iowa.


6


(d)


The
inspection
was
performed
by
or
on
behalf
of
the
home
7


state
licensing
authority,
if
available.
8


(e)
The
inspection
report
is
the
most
recent
report
9


available
that
satisfies
the
requirements
of
this
paragraph
10


“c”
.
11


(2)
If
the
home
state
licensing
authority
has
not
conducted
12


an
inspection
satisfying
the
requirements
of
this
paragraph
13


“c”
,
the
pharmacy
may
submit
an
inspection
report
from
the
14


national
association
of
boards
of
pharmacy’s
verified
pharmacy
15


program,
or
the
pharmacy
may
submit
an
inspection
report
from
16


another
qualified
entity
if
preapproved
by
the
board,
if
the


17


inspection
report
satisfies
all
of
the
other
requirements
of
18


this
paragraph
“c”
.
19


(3)
The
board
may
recover
from
a
nonresident
pharmacy,
prior
20


to
the
issuance
of
a
license
or
renewal,
the
costs
associated


21


with
conducting
an
inspection
by
or
on
behalf
of
the
board


22


for
purposes
of
satisfying
the
requirement
in
subparagraph
23


(1),
subparagraph
division
(d).
In
addition,
the
nonresident
24


pharmacy
shall
submit
evidence
of
corrective
actions
for
all


25


deficiencies
noted
in
the
inspection
report
and
shall
submit


26


evidence
of
compliance
with
all
legal
directives
of
the
home
27


state
regulatory
or
licensing
authority.
28


d.
Submit
evidence
that
the
nonresident
pharmacy
maintains
29


records
of
the
controlled
substances
delivered,
dispensed,
or
30


distributed
to
ultimate
users
in
this
state


has
submitted
an
31


application
to
register
with
the
Iowa
prescription
monitoring


32


program,
except
as
otherwise
provided
in
this
paragraph


.
The
33


prescription
monitoring
program
registration
shall
be
issued


34


if
the
nonresident
pharmacy
license
application
is
granted.


35


-5-


LSB
1217DP
(3)
86


tr/nh
5/
13
























































S.F.
_____
H.F.
_____


If
the
nonresident
pharmacy
does
not
intend
to
dispense
or
1


distribute
controlled
substances
in
Iowa,
the
pharmacy
may,
in


2


lieu
of
registering
with
the
prescription
monitoring
program,
3


submit
an
application
for
exemption
from
reporting
to
the
4


prescription
monitoring
program.
5


e.
Submit
evidence
that
the
nonresident
pharmacy
provides
,


6


during
its
regular
hours
of
operation
for
at
least
six
days


7


and
for
at
least
forty
hours
per
week,
a
toll-free
telephone
8


service
to
facilitate
communication
between
ultimate
users
in
9


this
state
and
,
the
telephone
number
of
which
is
printed
on
the
10


label
affixed
to
each
prescription
dispensed
or
distributed
11


in
Iowa,
that
allows
patients
to
speak
with
a
pharmacist
who
12


has
access
to
the
ultimate
user’s
patient
records
in
the
13


nonresident
pharmacy,
and
that
the
toll-free
number
is
printed
14


on
the
label
affixed
to
each
container
of
prescription
drugs
15


delivered,
dispensed,
or
distributed
in
this
state
at
least
six
16


days
per
week
for
a
total
of
at
least
forty
hours


.
17


2.
Pharmacist
license
requirement.
At
least
one
pharmacist
18


employed
by
the
nonresident
pharmacy,
who
shall
be
the
19


pharmacist
in
charge
of
the
nonresident
pharmacy,
shall
20


maintain
a
current
license
to
practice
pharmacy
in
Iowa
during


21


any
period
that
the
nonresident
pharmacy
is
licensed
by
the


22


board.
23


2.
3.
License
renewal.
A
nonresident
pharmacy
shall
renew
24


its
license
on
or
before
January
1
annually.
In
order
to
renew
25


a
nonresident
pharmacy
license,
a
nonresident
pharmacy
shall
26


submit
a
renewal


completed
application
and
fee
as
determined
27


by
the
board,
and
shall
fulfill
all
of
the
requirements
of
28


subsection
1
,
paragraphs
“b”
through
“e”
.
A
nonresident
29


pharmacy
shall
pay
an
additional
fee
for
late
renewal
as
30


determined
by
the
board.
31


4.


License
denial.
The
board
shall
refuse
to
issue
32


a
nonresident
pharmacy
license
for
failure
to
meet
the


33


requirements
of
subsection
1.
The
board
may
refuse
to
issue


34


or
renew
a
license
for
any
grounds
under
which
the
board


35


-6-


LSB
1217DP
(3)
86


tr/nh
6/
13



















































S.F.
_____
H.F.
_____


may
impose
discipline.
License
or
renewal
denials
shall
be
1


considered
contested
cases
governed
by
chapter
17A.


2


3.
5.
Discipline.
The
board
may
deny
fine
,
suspend,
or
3


revoke
,
or
impose
other
disciplinary
sanctions
on
a
nonresident
4


pharmacy
license
for
any
violation
of
this
section
,
section
5


155A.15,
subsection
2


,
paragraph
“a”
,
“b”
,
“d”
,
“e”
,
“f”
,
“g”
,
6


“h”


,
or
“i”
,
chapter
124
,
124A
,
124B
,
126
,
or
205
,
or
a
rule
of
7


the
board.
of
the
following:
8


a.
Any
violation
of
the
federal
Food,
Drug,
and
Cosmetic
Act
9


or
federal
regulations
promulgated
under
the
Act.
A
warning
10


letter
issued
by
the
United
States
food
and
drug
administration
11


shall
be
conclusive
evidence
of
a
violation.
12


b.
Any
conviction
of
a
crime
related
to
prescription
drugs
13


or
the
practice
of
pharmacy
committed
by
the
nonresident
14


pharmacy,
pharmacist
in
charge,
or
individual
owner,
or
if
the
15


pharmacy
is
an
association,
joint
stock
company,
partnership,
16


or
corporation,
by
any
managing
officer.


17


c.
Refusing
access
to
the
pharmacy
or
pharmacy
records
to
an
18


agent
of
the
board
for
the
purpose
of
conducting
an
inspection
19


or
investigation.
20


d.


Any
violation
of
this
chapter
or
chapter
124,
124A,
124B,
21


126,
or
205,
or
rule
of
the
board.


22


Sec.
6.
NEW
SECTION
.
155A.13C
Outsourcing
facility
license
23


——
renewal,
cancellation,
denial,
discipline.
24


1.
License
required.
Any
compounding
facility
that
is
25


registered
as
an
outsourcing
facility,
as
defined
in
21
26


U.S.C.
§353b,
that
distributes
sterile
compounded
human
27


drug
products
without
a
patient-specific
prescription
to
an
28


authorized
agent
or
practitioner
in
this
state
shall
obtain
an
29


outsourcing
facility
license
from
the
board
prior
to
engaging
30


in
such
distribution.
If
an
outsourcing
facility
dispenses
31


prescription
drugs
pursuant
to
patient-specific
prescriptions
32


to
patients
in
Iowa,
the
outsourcing
facility
shall
obtain
and
33


maintain
a
valid
Iowa
pharmacy
license
or
Iowa
nonresident
34


pharmacy
license
under
this
chapter.
The
board
shall
make
35


-7-


LSB
1217DP
(3)
86


tr/nh
7/
13




































































S.F.
_____
H.F.
_____


available
an
application
form
for
an
outsourcing
facility
1


license
and
shall
require
such
information
it
deems
necessary
2


to
fulfill
the
purposes
of
this
section.
An
outsourcing
3


facility
shall
do
all
of
the
following
in
order
to
obtain
an
4


outsourcing
facility
license
from
the
board:
5


a.
Submit
a
completed
application
form
and
application
fee
6


as
determined
by
the
board.
7


b.
Submit
evidence
of
possession
of
a
valid
registration
as
8


an
outsourcing
facility
with
the
United
States
food
and
drug
9


administration.
10


c.
If
one
or
more
inspections
have
been
conducted
by
the
11


United
States
food
and
drug
administration
in
the
five-year
12


period
immediately
preceding
the
application,
submit
a
copy
13


of
any
correspondence
from
the
United
States
food
and
drug
14


administration
as
a
result
of
the
inspection,
including
but
15


not
limited
to
any
form
483s,
warning
letters,
or
formal
16


responses,
and
all
correspondence
from
the
applicant
to
the
17


United
States
food
and
drug
administration
related
to
such
18


inspections,
including
but
not
limited
to
formal
responses
and
19


corrective
action
plans.
In
addition,
the
applicant
shall
20


submit
evidence
of
correction
of
all
deficiencies
discovered
in
21


such
inspections
and
evidence
of
compliance
with
all
directives
22


from
the
United
States
food
and
drug
administration.
23


d.
Submit
evidence
that
the
supervising
pharmacist,
as
24


described
in
21
U.S.C.
§353b(a),
holds
a
valid
pharmacist
25


license
in
the
state
in
which
the
facility
is
located
and
that
26


such
license
is
in
good
standing.
27


2.
License
renewal.
An
outsourcing
facility
shall
renew
28


its
license
on
or
before
January
1
annually.
In
order
to
renew
29


an
outsourcing
facility
license,
an
outsourcing
facility
shall
30


submit
a
completed
application
and
fee
as
determined
by
the
31


board,
and
shall
fulfill
all
of
the
requirements
of
subsection
32


1.
An
outsourcing
facility
shall
pay
an
additional
fee
for
33


late
renewal
as
determined
by
the
board.
34


3.
License
cancellation.
If
a
facility
ceases
to
be
35


-8-


LSB
1217DP
(3)
86


tr/nh
8/
13



S.F.
_____
H.F.
_____


registered
as
an
outsourcing
facility
with
the
United
States
1


food
and
drug
administration,
the
facility
shall
notify
the
2


board
in
writing
and
shall
surrender
its
Iowa
outsourcing
3


facility
license
to
the
board
within
thirty
days
of
such
4


occurrence.
Upon
receipt,
the
board
shall
administratively
5


cancel
the
outsourcing
facility
license.
6


4.
License
denial.
The
board
shall
refuse
to
issue
7


an
outsourcing
facility
license
for
failure
to
meet
the
8


requirements
of
subsection
1.
The
board
may
refuse
to
issue
9


or
renew
a
license
for
any
grounds
under
which
the
board
10


may
impose
discipline.
License
or
renewal
denials
shall
be
11


considered
contested
cases
governed
by
chapter
17A.
12


5.
Discipline.
The
board
may
fine,
suspend,
revoke,
or
13


impose
other
disciplinary
sanctions
on
an
outsourcing
facility
14


license
for
any
of
the
following:
15


a.
Any
violation
of
the
federal
Food,
Drug,
and
Cosmetic
Act
16


or
federal
regulations
promulgated
under
the
Act.
A
warning
17


letter
issued
by
the
United
States
food
and
drug
administration
18


shall
be
conclusive
evidence
of
a
violation.
19


b.
Any
conviction
of
a
crime
related
to
prescription
drugs
20


or
the
practice
of
pharmacy
committed
by
the
outsourcing
21


facility,
supervising
pharmacist,
or
individual
owner,
or
22


if
the
outsourcing
facility
is
an
association,
joint
stock
23


company,
partnership,
or
corporation,
by
any
managing
officer.
24


c.
Refusing
access
to
the
outsourcing
facility
or
facility
25


records
to
an
agent
of
the
board
for
the
purpose
of
conducting
26


an
inspection
or
investigation.
27


d.
Any
violation
of
this
chapter
or
chapter
124,
124A,
124B,
28


126,
or
205,
or
rule
of
the
board.
29


Sec.
7.
Section
155A.26,
subsections
2,
3,
and
4,
Code
2015,
30


are
amended
to
read
as
follows:
31


2.
Make
audits
of
the
supply
and
inventory
of
controlled
32


substances
and
prescription
drugs
in
the
possession
of
any
and
33


all
individuals
or
institutions
authorized
to
have
possession
34


of
any
controlled
substances
or
prescription
drugs
,
regardless


35


-9-


LSB
1217DP
(3)
86


tr/nh
9/
13




S.F.
_____
H.F.
_____


of
the
location
of
the
individual
or
institution
.
1


3.
Conduct
routine
and
unannounced
inspections
of
2


pharmacies,
drug
wholesalers,
and
the
offices
or
business
3


locations
of
all
individuals
and
institutions
authorized
to
4


have
possession
of
prescription
drugs
including
controlled
5


substances
or
prescription
devices
,
regardless
of
the
location


6


of
the
office
or
business


.
7


4.
Conduct
inspections
and
investigations
related
to
the
8


practice
of
pharmacy
and
the
distribution
of
prescription
drugs
9


and
devices
in
and
into
this
state.
10


Sec.
8.
Section
155A.33,
Code
2015,
is
amended
to
read
as
11


follows:
12


155A.33
Delegation
of
technical
functions.
13


A
pharmacist
may
delegate
technical
dispensing
functions
14


to
pharmacy
technicians,
but
only
if
the
pharmacist
is
15


physically
present
to
verify
the
accuracy
and
completeness
16


of
the
patient’s
prescription
prior
to
the
delivery
of
the
17


prescription
to
the
patient
or
the
patient’s
representative.
18


However,
the
physical
presence
requirement
does
not
apply
when
19


a
pharmacist
is
utilizing
an
automated
dispensing
system
or
20


a
tech-check-tech
program
or
when
a
pharmacist
is
remotely


21


supervising
a
certified
pharmacy
technician
practicing
at


22


a
telepharmacy
site
approved
by
the
board
.
When
using
an
23


automated
dispensing
system
or
a
tech-check-tech
program
,
or
24


when
remotely
supervising
a
certified
pharmacy
technician


25


practicing
at
an
approved
telepharmacy
site


,
the
pharmacist
26


shall
utilize
an
internal
quality
control
assurance
plan
that
27


ensures
accuracy
for
dispensing.
Verification
of
automated
28


dispensing
,
and
tech-check-tech
,
and
telepharmacy
practice
29


accuracy
and
completeness
remains
the
responsibility
of
the
30


pharmacist
and
shall
be
determined
in
accordance
with
rules
31


adopted
by
the
board.
32


Sec.
9.
NEW
SECTION


.
155A.45
Inspection
reports
——
33


disclosure.
34


Notwithstanding
section
272C.6,
subsection
4,
paragraph
“a”
,
35


-10-


LSB
1217DP
(3)
86


tr/nh
10/
13

















S.F.
_____
H.F.
_____


an
inspection
report
in
possession
of
the
board,
regardless
1


of
whether
the
report
is
based
on
a
routine
inspection
or
an
2


inspection
prompted
by
one
or
more
complaints,
may
be
disclosed
3


to
the
national
association
of
boards
of
pharmacy’s
inspection
4


network.
5


EXPLANATION
6


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
7


the
explanation’s
substance
by
the
members
of
the
general
assembly.
8


This
bill
relates
to
the
operation
of,
and
persons
and
9


activities
regulated
by,
the
board
of
pharmacy.
10


The
bill
provides
for
remote
pharmacist
supervision
of
11


a
certified
pharmacy
technician
practicing
at
an
approved
12


telepharmacy
practice
site,
pursuant
to
rules
of
the
board.
13


The
bill
permits
the
board
to
recommend,
subject
to
approval
14


by
the
governor,
a
pool
of
up
to
seven
qualified
individuals
15


to
serve
as
alternate
board
members
to
ensure
the
availability
16


of
an
unbiased
quorum
of
board
members
to
hear
a
contested
17


case.
The
bill
identifies
the
maximum
term
for
an
alternate
18


board
member,
provides
that
an
individual
who
previously
served
19


on
the
board
may
serve
as
an
alternate
board
member,
provides
20


for
compensation
when
the
alternate
member
serves
on
a
hearing
21


panel,
establishes
requirements
for
the
composition
of
a
22


hearing
panel
containing
alternate
board
members,
and
provides
23


that
the
decision
of
a
hearing
panel
containing
alternate
board
24


members
is
considered
a
final
decision
of
the
board.
25


The
bill
amends
the
definitions
of
“device”
and
“dispense”
26


to
more
closely
align
with
industry
standard
definitions
and
to
27


clarify
the
activities
that
may
be
included
as
a
function
of
28


dispensing.
The
bill
also
defines
the
terms
“equipment”
and
29


“telepharmacy”
as
they
relate
to
the
practice
of
pharmacy.
30


The
bill
amends
provisions
relating
to
the
licensure
of
31


nonresident
pharmacies
that
provide
prescription
pharmaceutical
32


products
to
patients
located
in
Iowa.
The
bill
requires
the
33


pharmacist
in
charge
of
a
nonresident
pharmacy
to
maintain
34


a
license
to
practice
pharmacy
in
Iowa.
The
bill
clarifies
35


-11-


LSB
1217DP
(3)
86


tr/nh
11/
13



S.F.
_____
H.F.
_____


the
information
required
for
license
application,
including
1


evidence
of
recent
inspection
of
the
pharmacy
and
defining
the
2


elements
of
an
acceptable
inspection.
The
bill
describes
and
3


identifies
various
entities
that
may
be
employed
to
perform
an
4


inspection
acceptable
for
Iowa
licensure.
The
bill
authorizes
5


the
board
to
recoup
from
a
nonresident
pharmacy
any
costs
6


incurred
by
the
board
in
completing
an
inspection
of
the
7


nonresident
pharmacy
if
the
nonresident
pharmacy
cannot
provide
8


an
acceptable
inspection
report.
9


The
bill
requires
that
an
applicant
for
a
nonresident
10


pharmacy
license
must
include
with
the
application
either
11


evidence
that
the
nonresident
pharmacy
has
registered
to
12


submit
controlled
substances
prescription
records
to
the
13


Iowa
prescription
monitoring
program
(PMP)
or
has
requested
14


exemption
from
reporting
to
the
PMP
based
on
exemption
criteria
15


established
by
the
board
pursuant
to
Code
section
124.552.
The
16


bill
eliminates
the
requirement
that
a
nonresident
pharmacy
17


maintain
minimum
hours
and
days
of
operation,
requiring
in
18


lieu
thereof
that
a
pharmacist
with
access
to
patient
records
19


be
readily
available
to
speak
to
patients
via
a
toll-free
20


telephone
number
at
least
six
days
per
week
for
a
total
of
at
21


least
40
hours.
22


The
bill
authorizes
the
board
to
deny
an
application
for
a
23


nonresident
pharmacy
license
if
the
applicant
fails
to
meet
the
24


application
requirements
and
authorizes
the
board
to
refuse
to
25


issue
or
renew
a
nonresident
pharmacy
license
for
any
grounds
26


under
which
the
board
may
impose
discipline.
27


The
bill
amends
the
grounds
for
disciplining
nonresident
28


pharmacies.
The
board
may
impose
discipline
for
any
violation
29


of
the
federal
Food,
Drug,
and
Cosmetic
Act
or
regulations
30


promulgated
under
the
Act
including
the
issuance
by
the
United
31


States
food
and
drug
administration
of
a
warning
letter;
32


conviction
of
a
crime
related
to
prescription
drugs
or
the
33


practice
of
pharmacy
by
the
owner,
managing
officer,
or
the
34


pharmacy;
refusal
to
provide
the
board’s
agent
access
to
the
35


-12-


LSB
1217DP
(3)
86


tr/nh
12/
13



S.F.
_____
H.F.
_____


pharmacy
or
pharmacy
records
for
purposes
of
inspection
or
1


investigation;
and
any
violation
of
Iowa
law
or
rule
of
the
2


board
relating
to
the
practice
of
pharmacy
and
the
distribution
3


of
prescription
products
in
Iowa.
For
nonresident
pharmacies,
4


the
bill
adds
that
the
board
has
the
option
to
fine
the
5


nonresident
pharmacy,
in
addition
to
license
suspension,
6


revocation,
and
other
sanctions.
7


The
bill
adds
a
new
license
classification
for
outsourcing
8


facilities,
for
the
purpose
of
licensing
and
regulating
any
9


compounding
facility
that
is
registered
under
federal
law
as
an
10


outsourcing
facility.
The
bill
establishes
the
requirements
11


for
application
and
licensure;
license
renewal,
cancellation,
12


and
denial;
and
establishes
grounds
for
discipline
of
the
13


outsourcing
facility
license
identical
to
the
disciplinary
14


procedure
available
regarding
nonresident
pharmacies.
15


The
bill
clarifies
that
the
officers,
agents,
inspectors,
16


and
representatives
of
the
board
may
perform
functions
and
17


activities
relating
to
authorized
enforcement
activities
18


regardless
of
the
location
of
the
office
or
business
that
is
19


the
subject
of
the
enforcement
activities.
The
bill
authorizes
20


the
board
to
provide
reports
of
inspections
of
board
licensees
21


to
the
national
association
of
boards
of
pharmacy’s
inspection
22


network,
a
closed
network
of
information
regarding
individual
23


states’
licensees
that
compiles
information
and
makes
that
24


information
available
to
other
state
boards
of
pharmacy
for
25


purposes
of
regulating
the
subject
licensees.


26


-13-


LSB
1217DP
(3)
86


tr/nh
13/
13

